SHANGHAI,Feb. 25,2025 -- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company"),a leading and fast-growing express delivery company inChina,today announced that it will release its unaudited financial results for the fourth quarter ended December 31,2024 and its unaudited annual results for the fiscal year ended December 31,2024,after the U.S. market closes on March 18,2025.
ZTO's management team will host an earnings conference call at 8:30 P.M. U.S. Eastern Time on Tuesday,March 18,2025,which is 8:30 A.M. Beijing Time on Wednesday,March 19,2025.
Dial-in details for the earnings conference call are as follows:
United States:
1-888-317-6003
Hong Kong:
800-963976
Singapore:
800-120-5863
Mainland China:
4001-206115
International:
1-412-317-6061
Passcode:
9429827
A replay of the conference call may be accessible through March 25,2025 by dialing the following numbers:
United States:
1-877-344-7529
International:
1-412-317-0088
Canada:
855-669-9658
Passcode:
8404611
A live and archived webcast of the conference call will also be available at the Company's investor relations website at http://zto.investorroom.com.
About ZTO Express (Cayman) Inc.
ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company") is a leading and fast-growing express delivery company inChina. ZTO provides express delivery service as well as other value-added logistics services through its extensive and reliable nationwide network coverage inChina.
ZTO operates a highly scalable network partner model,which the Company believes is best suited to support the significant growth of e-commerce inChina. The Company leverages its network partners to provide pickup and last-mile delivery services,while controlling the mission-critical line-haul transportation and sorting network within the express delivery service value chain.
For more information,please visit http://zto.investorroom.com.
For investor inquiries,please contact:
Investor Relations
Tel: (86) 21 5980 4508
Email: [email protected]
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
Six new models announced for AI-enhanced gaming,streaming,and creation with 8K visuals and optimized thermal design with triple FrostBlade 4.0 cooling fans
SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors